| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/16/2009 | EP1399479B1 Cation conducting gaba a receptors and their use |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | EP1192125B9 Mono-substituted 3-propyl gamma-aminobutyric acids |
| 09/16/2009 | EP1126878B1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/16/2009 | EP1083899B1 Derivatives of 1-deoxy-galactonojirimycin and their use in the treatment of lysosomal storage diseases by enhancing lysosomal alpha-galactosidase a |
| 09/16/2009 | EP1027443B1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 09/16/2009 | CN101534823A Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531704A Peptide-based compounds |
| 09/16/2009 | CN101531696A Application of steroid saponin terpenoids and derivatives thereof in preparing medicine for treating purine metabolic disturbance diseases |
| 09/16/2009 | CN101531653A Salts of 3-(4-amino-1-oxo-1,3-dihydro-iso-indol-2-yl)piperdine-2,6-dione and derivatives thereof, polymorph of the salts, preparation and application thereof |
| 09/16/2009 | CN101531637A A novel compound capable of restraining and blocking M2 ion channel activity and application thereof |
| 09/16/2009 | CN101530557A A Chinese medicine combination for curing vocal nodules |
| 09/16/2009 | CN101530495A Method for preparing phellodendron extract by applying membrane filtration technology |
| 09/16/2009 | CN101530411A Application for taking NO donor-type compounds as P-glycoprotein inhibitors and tumor multi-drug resistance reversal agents |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
| 09/16/2009 | CN100540001C Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 09/15/2009 | US7589202 Substituted pyrazoles |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
| 09/15/2009 | US7589108 3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-indole hydrochloride for treatment of central nervous system disorders associated with 5-HT serotonin receptors |
| 09/15/2009 | US7589105 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound |
| 09/15/2009 | US7589097 Using compounds such as 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine for therapy of Parkinson's disease; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 09/15/2009 | US7589096 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | US7588753 Synergistically pro-penetrating solutions for ungual/peri-ungual dermatological/cosmetic applications |
| 09/15/2009 | CA2473991C Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
| 09/15/2009 | CA2429220C Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 09/15/2009 | CA2415065C Oral compositions comprising host-response modulating agent |
| 09/15/2009 | CA2409819C Triazole derivatives |
| 09/15/2009 | CA2408417C Local anesthetic methods and kits |
| 09/15/2009 | CA2407754C Prodrugs of hiv replication inhibiting pyrimidines |
| 09/15/2009 | CA2379696C Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 09/15/2009 | CA2376835C Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| 09/15/2009 | CA2372560C Cyanopyrroles for binding the progesterone receptor |
| 09/15/2009 | CA2362363C Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 09/15/2009 | CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors |
| 09/15/2009 | CA2323111C New substituted indolinones, the preparation thereof and their use as pharmaceutical compositions |
| 09/15/2009 | CA2274204C Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole] |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/11/2009 | WO2009110646A1 Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 09/11/2009 | WO2009110612A1 New compound derived from germinated brown rice, and agent containing said compound as an active ingredient for prevention or amelioration of neuropathy |
| 09/11/2009 | WO2009110546A1 Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same |
| 09/11/2009 | WO2009110526A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 3',5-di-2-propenyl-(1,1'-biphenyl)-2,4'-diol as active ingredient |
| 09/11/2009 | WO2009110520A1 Heterocyclic compound |
| 09/11/2009 | WO2009110510A1 Alkylaminopyridine derivative |
| 09/11/2009 | WO2009110495A1 Promoter for secretion of insulin-like growth factor-1, and food or beverage containing the same |
| 09/11/2009 | WO2009110468A1 Potassium channel opener |
| 09/11/2009 | WO2009110416A1 Concomitant drug |
| 09/11/2009 | WO2009110415A1 Concomitant drug |
| 09/11/2009 | WO2009110324A1 Method for regulation of expression of low-density lipoprotein receptor, and enhancer of expression of low-density lipoprotein receptor |
| 09/11/2009 | WO2009110235A1 Combined use of cholestanol derivative |
| 09/11/2009 | WO2009110205A1 Agent for increasing the quantity of hyaluronic acid |
| 09/11/2009 | WO2009110041A1 Cancer therapeutic agent by agent for cancer-specific introduction of prostacyclin receptor antagonist |
| 09/11/2009 | WO2009109983A1 Thieno[2,3-d]-pyrimidine-4(3h)-one compounds with antifungal properties and process thereof |
| 09/11/2009 | WO2009061889A4 Grape polyphenolics for platelet and bacterial control |
| 09/11/2009 | WO2004035811A3 Kinase modulation assay |
| 09/11/2009 | CA2717135A1 Combined use of cholestanol derivative |
| 09/11/2009 | CA2714617A1 Alkylaminopyridine derivative |
| 09/10/2009 | US20090227809 New 2-(alpha-hydroxypentyl) benzoates, their preparations and their uses |
| 09/10/2009 | US20090227768 Anti-Allergic Complex Molecules |
| 09/10/2009 | US20090227688 Admixture of carotenoids having provitamin a activity and carotenoids devoid of provitamin a activity for treating aging symptoms |
| 09/10/2009 | US20090227664 Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227639 Human protein tyrosine phosphatase inhibitors and methods of use |
| 09/10/2009 | US20090227608 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 09/10/2009 | US20090227592 Compounds effecting glucokinase |
| 09/10/2009 | US20090227564 Drug for prevention and/or therapy of endometriosis |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227530 Sodium channel blockers |
| 09/10/2009 | US20090227526 Cytoprotective composition comprising hesperidin or pharmaceutically acceptable salt thereof as an active ingredient |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227014 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/10/2009 | US20090226503 Adhesion inhibiting material for vertebral/spinal operation |
| 09/10/2009 | US20090226483 Super brown cream |
| 09/10/2009 | US20090226477 Pth2 receptor selective compounds |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226415 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/10/2009 | US20090226408 Anti-fatigue composition |
| 09/10/2009 | US20090226406 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 09/10/2009 | US20090226403 Olfactory and pheromones G-protein coupled receptors |
| 09/10/2009 | US20090226371 Fluorescent nanoparticles |
| 09/10/2009 | US20090226366 Choline: Early Detector of Cancer |
| 09/10/2009 | DE102008003467A1 Flavonoide als Mittel zur Prophylaxe und Behandlung von neurodegenerativen und anderen Proteinfehlfaltungskrankheiten Flavonoids as a means for the prophylaxis and treatment of neurodegenerative diseases and other protein misfolding |
| 09/09/2009 | EP2098598A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 09/09/2009 | EP2098519A1 Process for the synthesis of ramelteon and its intermediates |
| 09/09/2009 | EP2098517A1 Novel phenyl-isoxazol-3-ol derivative |
| 09/09/2009 | EP2098248A1 Combination of anticholinergics, glucocorticoids and beta2-agonists for the treatment of inflammatory diseases |
| 09/09/2009 | EP2098247A2 Prevention and treatment of androgen-deprivation induced loss of BMD or bone fractures |
| 09/09/2009 | EP2098240A1 Agent for promoting healing of living body |
| 09/09/2009 | EP2098230A1 Use of cytoskeletal inhibitors in crystalline form for the inhibition or prevention of restenosis |
| 09/09/2009 | EP2098228A1 Antiinflammatory agent comprising 2-aminophenol or derivative thereof as active ingredient |